Skip to content
The Nexus
DossierENTITY

Serena Williams

Coverage of Serena Williams in the Nexus archive.

Earliest in view: Apr 24 · 14:00 UTCMost recent: Jul 3 · 05:33 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSJul 3 · 05:33 UTCBUSINESS INSIDER
    Maria Sharapova says she started preparing for retirement years before leaving tennis

    Maria Sharapova prepared for life after tennis by taking business courses, internships, and building her brand during breaks from the sport. She emphasized planning for a second act, using her platform to invest in ventures like Sugarpova and gaining experience at the NBA.

  • HEALTHJun 20 · 13:00 UTCTHE ATLANTIC
    Are GLP-1s Performance-Enhancing Drugs?

    Serena Williams, a paid spokesperson for telehealth company Ro, used GLP-1 weight-loss drugs to lose 34 pounds and claims the medication improved her training and tennis performance. The article explores whether GLP-1s should be classified as performance-enhancing drugs, noting the World Anti-Doping Agency is monitoring their use, though current rules allow athletes to take them.

  • BUSINESSJun 8 · 09:02 UTCMARKETWATCH
    Serena Williams is making a comeback; these are the properties that built her $35 million real estate portfolio

    Serena Williams is making a comeback in tennis and has accumulated a $35 million real estate portfolio through years of property acquisitions.

  • BUSINESSJun 6 · 11:02 UTCFORTUNE
    Serena Williams’ secret to success is about more than talent: You have to grind ‘every day’

    Serena Williams emphasizes daily dedication as key to success in both tennis and business. She returns to competition at the HSBC Championships in doubles with Victoria Mboko and continues her work with Serena Ventures, a venture fund supporting diverse entrepreneurs. Williams advises founders to persist through challenges and maintain humility.

  • HEALTHJun 6 · 10:05 UTCBUSINESS INSIDER
    Serena Williams' comeback is huge for peptide bros

    Serena Williams announced her return to tennis at age 44 for a doubles match in London, crediting GLP-1 peptides for weight loss and improved mobility. Her comeback highlights growing interest in peptides among athletes and health enthusiasts for performance and longevity benefits.

  • POLITICSJun 5 · 09:02 UTCNPR NEWS
    The quiz tracked Trump's wins and losses this week. Can you win bigly?

    The article introduces a quiz tracking Donald Trump's recent wins and losses, alongside mentions of Serena Williams, Peabo Bryson, Kalshi, and United Airlines. It challenges readers to test their knowledge of these references.

  • POLITICSJun 2 · 00:31 UTCCROSSCUT SEATTLE
    News Wrap: Arrests rise outside New Jersey ICE facility

    Police in New Jersey arrested protestors for breaking a curfew near an ICE detention facility. Other developments include the release of election denier Tina Peters from prison, Colombia's presidential election moving to a runoff, Kenyan protests against a U.S.-planned Ebola quarantine facility, and Serena Williams returning to tennis.

  • HEALTHApr 24 · 14:00 UTCTHE VERGE
    I don’t think Gwyneth Paltrow knows what a peptide is

    The article discusses the rising popularity of peptides, citing examples like online videos of people injecting 'Wolverine stack' peptides, Serena Williams' Ro ads promoting GLP-1 access, and RFK Jr.'s advocacy for expanded peptide access. It questions Gwyneth Paltrow's understanding of peptides despite her public association with wellness trends.